์•ˆ๋…•ํ•˜์„ธ์š”. 

์˜๋ฃŒ๊ฒฝ์˜ ๋‰ด์Šค๋ ˆํ„ฐ์ž…๋‹ˆ๋‹ค.๐Ÿฃ


์ค‘๊ฐ„๊ณ ์‚ฌ ๊ธฐ๊ฐ„์ด ๋๋‚˜์ž๋งˆ์ž ๊ฒจ์šธ์ด ์„ฑํผ ๋‹ค๊ฐ€์™”๋„ค์š”.
๊ฐ๊ธฐ ์กฐ์‹ฌํ•˜์‹œ๊ณ , ์ด๋ฒˆ ์ฃผ๋„ ๊ฑด๊ฐ• ์ฑ™๊ธฐ์‹œ๊ธธ ๋ฐ”๋ž๋‹ˆ๋‹ค.

์˜ค๋Š˜ ์ €๋„ํด๋Ÿฝ์—์„œ๋Š” ์•„๋ž˜ ๋‘ ๋…ผ๋ฌธ์„ ๋ฆฌ๋ทฐํ–ˆ์Šต๋‹ˆ๋‹ค.


  • Wang, Y., Liu, C., Hu, W., Luo, L., Shi, D., Zhang, J., ... & He, M. (2024). Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case. NPJ Digital Medicine, 7(1), 43.
  • Hoffman, G. J., Lei, L., Alam, I., Kim, M., Min, L., Fan, Z., & Levine, D. (2025). Medicare Advantage Plan Disenrollment: Beneficiaries Cite Access, Cost, And Quality Among Reasons For Leaving: Article examines factors associated with beneficiary disenrollment from Medicare Advantage plans. Health Affairs, 44(6), 684-692.

๐Ÿ“‘ ์ €์ž‘๊ถŒ ์•ˆ๋‚ด

  • ์˜คํ”ˆ ์•ก์„ธ์Šค(CC BY ๋“ฑ) ๋˜๋Š” ๋ฒˆ์—ญยท์š”์•ฝ์ด ํ—ˆ์šฉ๋œ ๋…ผ๋ฌธ๋งŒ ๋‰ด์Šค๋ ˆํ„ฐ์— ๋ฆฌ๋ทฐ๋กœ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

  • ์ œํ•œ๋œ ๋…ผ๋ฌธ์€ ์›๋ฌธ ๋งํฌ์™€ ๊ฐ„๋‹จํ•œ ์ฝ”๋ฉ˜ํŠธ๋งŒ ์ œ๊ณตํ•˜๋ฉฐ, ์—ฐ๊ตฌ์‹ค ๊ตฌ์„ฑ์›๋“ค์€ ๋‚ด๋ถ€ ์•„์นด์ด๋ธŒ๋ฅผ ์ฐธ๊ณ ํ•ด์ฃผ์„ธ์š”๐Ÿฅฐ

Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case


์ €์ž: Yueye Wang, Chi Liu, Wenyi Hu, Lixia Luo, Danli Shi, Jian Zhang, Qiuxia Yin, Lei Zhang, Xiaotong Han, Mingguang He

์ €๋„/IF/์—ฐ๋„: npj Digital Medicine (IF 15.1), 2024 

Copyright: CC-BY-4.0 (๋ณต์‚ฌ ๋ฐ ๋ฐฐํฌ, ์ƒ์—…์  ์‚ฌ์šฉ, 2์ฐจ ์ €์ž‘๋ฌผ ์ œ์ž‘ ๊ฐ€๋Šฅ)
DOI: https://www.nature.com/articles/s41746-024-01032-9

๐Ÿ”Ž ์—ฐ๊ตฌ ๋ฐฐ๊ฒฝ
  • AI์˜ ๋†’์€ ์ •ํ™•๋„๊ฐ€ ๋ฐ˜๋“œ์‹œ ๊ฒฝ์ œ์  ๊ฐ€์น˜(cost-effectiveness)๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Œ์„ ์ง€์ ํ•จ.
  • ์‹ค์ œ ์ค‘๊ตญ ๊ตญ๊ฐ€ DR ๊ฒ€์ง„ ๋ฐ์ดํ„ฐ๋ฅผ ํ™œ์šฉํ•ด AI ์„ฑ๋Šฅ(๋ฏผ๊ฐ๋„ยทํŠน์ด๋„)์— ๋”ฐ๋ฅธ ๋น„์šฉํšจ๊ณผ์„ฑ ์ฐจ์ด๋ฅผ ๋ถ„์„ํ•จ.
  • AI ํ‰๊ฐ€์˜ ์ดˆ์ ์„ โ€˜์ •ํ™•๋„ ์ค‘์‹ฌโ€™์—์„œ โ€˜๊ฐ€์น˜ ์ค‘์‹ฌ(Value-based)โ€™์œผ๋กœ ์ „ํ™˜ํ•  ํ•„์š”์„ฑ์„ ์ œ์‹œํ•จ.


๐Ÿงช ์—ฐ๊ตฌ ๋ฐฉ๋ฒ•

  • Lifeline Express ๊ฒ€์ง„ ๋ฐ์ดํ„ฐ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ๋ฏผ๊ฐ๋„ 69.8โ€“99.4%, ํŠน์ด๋„ 31.9โ€“92.6%์˜ 1,100๊ฐœ AI ์‹œ๋‚˜๋ฆฌ์˜ค๋ฅผ ์„ค์ •ํ•จ.
  • 30๋…„ ๊ธฐ๊ฐ„ ๋™์•ˆ Markov ๋ชจํ˜•์„ ํ™œ์šฉํ•ด ์งˆ๋ณ‘ ์ง„ํ–‰, ๋น„์šฉ, QALY ๋ณ€ํ™”๋ฅผ ์‹œ๋ฎฌ๋ ˆ์ด์…˜ํ•จ.
  • ๊ธฐ์ค€ ๋ชจ๋ธ(status quo, Se 93.3%, Sp 87.7%)๊ณผ ๋น„๊ตํ•ด ๊ฐ ์‹œ๋‚˜๋ฆฌ์˜ค์˜ ICER๊ณผ NMB๋ฅผ ๊ณ„์‚ฐํ•จ.


๐Ÿ“Š ์ฃผ์š” ๊ฒฐ๊ณผ

  • ๋ฏผ๊ฐ๋„ 88.2% ์ด์ƒ ๋˜๋Š” ํŠน์ด๋„ 80.4% ์ด์ƒ์ผ ๋•Œ๋งŒ ๋น„์šฉํšจ๊ณผ์  ๋˜๋Š” ๋น„์šฉ์ ˆ๊ฐํ˜•์œผ๋กœ ๋‚˜ํƒ€๋‚จ.
  • ๊ฐ€์žฅ ๋น„์šฉ์ ˆ๊ฐํ˜• ์‹œ๋‚˜๋ฆฌ์˜ค: Se 88.2%, Sp 90.3% โ†’ ๋น„์šฉ 554๋งŒ ๋‹ฌ๋Ÿฌ ์ ˆ๊ฐ, QALY 1,490 ์†์‹ค.
  • ๊ฐ€์žฅ ๋น„์šฉํšจ๊ณผํ˜• ์‹œ๋‚˜๋ฆฌ์˜ค: Se 96.3%, Sp 80.4% โ†’ ๋น„์šฉ 1,480๋งŒ ๋‹ฌ๋Ÿฌ ์ฆ๊ฐ€, QALY 839 ์ฆ๊ฐ€.
  • ์ „์ฒด 1,100๊ฐœ ์ค‘ 13๊ฐœ ์‹œ๋‚˜๋ฆฌ์˜ค(6๊ฐœ cost-saving, 7๊ฐœ cost-effective)๋งŒ ํšจ์œจ์ ์ž„.
  • PSA ๊ฒฐ๊ณผ, WTP = $30,828 ๊ธฐ์ค€์—์„œ ์ตœ์  AI์˜ ๋น„์šฉํšจ๊ณผ ์šฐ์›” ํ™•๋ฅ ์€ 55%๋กœ ๋‚˜ํƒ€๋‚จ.


โœ… ์‹œ์‚ฌ์ 

  • AI์˜ ์ •ํ™•๋„๋งŒ์œผ๋กœ๋Š” ์ž„์ƒ์ ยท๊ฒฝ์ œ์  ๊ฐ€์น˜๋ฅผ ํŒ๋‹จํ•  ์ˆ˜ ์—†์Œ์„ ์ž…์ฆํ•จ.
  • ์˜๋ฃŒ ํ™˜๊ฒฝ(์œ ๋ณ‘๋ฅ , WTP, ์ž์› ์ˆ˜์ค€)์— ๋”ฐ๋ผ ์ตœ์  ๋ฏผ๊ฐ๋„ยทํŠน์ด๋„ ์กฐํ•ฉ์ด ๋‹ฌ๋ผ์ง์„ ์ œ์‹œํ•จ.
  • ๋ณธ ์—ฐ๊ตฌ๋Š” ์˜๋ฃŒAI ํ‰๊ฐ€๋ฅผ ์ •ํ™•๋„ ์ค‘์‹ฌ์—์„œ โ€˜๊ฐ€์น˜ ์ค‘์‹ฌ(Value-based)โ€™ ํ‰๊ฐ€๋กœ ์ „ํ™˜ํ•ด์•ผ ํ•จ.


๐Ÿ’ฌ ๋žฉ ์ฝ”๋ฉ˜ํŠธ

  • AI์˜ performance๋ฅผ threshold๋งŒ ๋ฐ”๊ฟ”๊ฐ€๋ฉฐ ๋ฏผ๊ฐ๋„์™€ ํŠน์ด๋„๋ฅผ ๋ณ€ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ๋Š”๊ฐ€?
  • ๊ฒ€์ง„ํ”„๋กœ๊ทธ๋žจ์˜ ๊ฒฝ์ œ์„ฑ์„ ํ‰๊ฐ€ํ•  ๋•Œ (ํŠนํžˆ ์งˆํ™˜์— ๋”ฐ๋ผ) ์œ„์–‘์„ฑ์„ ๋‚ฎ์ถ”๋Š” ๊ฒƒ์ด ์ค‘์š”ํ•œ์ง€ ์œ„์Œ์„ฑ์„ ๋‚ฎ์ถ”๋Š” ๊ฒƒ์ด ์ค‘์š”ํ•œ์ง€ ํŒ๋‹จํ•ด์•ผ ํ•จ. ๊ทธ๋ฆฌ๊ณ  ์œ„์–‘์„ฑ ์ง„๋‹จ์‹œ ๋ฐœ์ƒํ•  ํ™•์ง„ ๊ฒ€์‚ฌ ๋น„์šฉ ๋“ฑ ์ถ”๊ฐ€ ๋น„์šฉ ๋˜ํ•œ ๊ณ ๋ คํ•ด์•ผ ํ•จ.


์ €์ž: Geoffrey J. Hoffman, Lianlian Lei, Ishrat Alam, Myra Kim, Lillian Min, Zhaohui Fan, and Deborah Levine
์ €๋„/IF/์—ฐ๋„: Health Affairs (IF 8.1), 2025

Copyright: CC BY-NC-ND 4.0 (๋น„์ƒ์—…์  ๊ณต์œ  ๊ฐ€๋Šฅ, ๋ฒˆ์—ญยท์š”์•ฝ ๋ถˆ๊ฐ€)

DOI: https://doi.org/10.1377/hlthaff.2024.01536

๐Ÿ’ฌ ๋žฉ ์ฝ”๋ฉ˜ํŠธ

  • Medicare Advantage (MA)์˜ ๊ฐœ๋…์ด ๋ฌด์—‡์ธ๊ฐ€? ๊ธฐ์กด์˜ ๋ฉ”๋””์ผ€์–ด์™€์˜ ์ฐจ์ด๋Š” ๋ฌด์—‡์ด๊ณ , ์–ด๋–ค ์žฅ์ ๊ณผ ๋‹จ์ ์ด ์žˆ๋Š”์ง€ ์ •๋ฆฌํ•ด๋ณผ ํ•„์š”๊ฐ€ ์žˆ์Œ. 

๐Ÿ“š์ด์ „์— ๋ฐœ์†ก๋˜์—ˆ๋˜ ์˜๋ฃŒ๊ฒฝ์˜ ๋‰ด์Šค๋ ˆํ„ฐ๋Š” ์•„์นด์ด๋ธŒ์—์„œ ๋ชจ์•„๋ณผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Follow us!
์—ฐ์„ธ๋Œ€ํ•™๊ต ์˜๋ฃŒ๊ฒฝ์˜์—ฐ๊ตฌ์‹ค
์ˆ˜์‹ ๊ฑฐ๋ถ€ Unsubscribe